AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06662929 — intervention group
Intervention type: RADIATION
Intervention: Radiation
Description: Radiotherapy for the Head \& Neck Cancer
Study NCT06662565 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral modification
Description: It includes:~.- Reducing or eliminating smoking and carbonated drinks.~* Weight loss in overweight or obese individuals.~* Caffeine Reduction: Limiting caffeine intake, especially for those consuming at least 400 mg per day.~* Consume Adequate Water: 6 to 8 glasses of water per day.~* Refrain from consuming fluids 2 to 3 hours before bedtime.~* Identify Bladder Irritants: such as sugar substitutes, citrus fruits, and tomato.~* Increasing fiber intake like fruits, and vegetables to reduce constipation with adequate hydration to make stools softer and easier to pass
Study NCT06662565 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral modification
Description: It includes:~.- Reducing or eliminating smoking and carbonated drinks.~* Weight loss in overweight or obese individuals.~* Caffeine Reduction: Limiting caffeine intake, especially for those consuming at least 400 mg per day.~* Consume Adequate Water: 6 to 8 glasses of water per day.~* Refrain from consuming fluids 2 to 3 hours before bedtime.~* Identify Bladder Irritants: such as sugar substitutes, citrus fruits, and tomato.~* Increasing fiber intake like fruits, and vegetables to reduce constipation with adequate hydration to make stools softer and easier to pass
Study NCT06662565 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic floor down-training
Description: Pelvic floor down training exercises aimed at promoting relaxation and deconditioning of the pelvic floor muscles (PFM). It will be practiced three sessions per week for 8 weeks.~Biofeedback-Assisted pelvic floor down-training:~Procedure:~* Rectal biofeedback will be inserted.~* The therapist asks the woman to focus on consciously relaxing and releasing the PFM after each contraction or exercise while watching biofeedback screen.~* Then, breathe deeply and fully into her abdomen, allowing her pelvic floor to naturally relax and lengthen.~* And to incorporate relaxation techniques such as visualization, or progressive muscle relaxation to promote overall muscle relaxation and reduce PFM tension.~* Exercises are typically repeated around 10-20 times per session. This number can vary depending on the patient's condition and tolerance, as well as the therapist's assessment and treatment plan.
Study NCT06663566 — intervention group
Intervention type: OTHER
Intervention: Diagnose the patients right heart function as well as right heart fibrosis
Description: Diagnose the patients right heart function as well as right heart fibrosis
Study NCT06124001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
Description: Intratumoral injection only. Dosing days may be Days 1-2 or Days 1-3.
Study NCT06124001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: camrelizumab for Injection
Description: Administered once at 3 mg/kg intravenously on Days 8 of each cycle.
Study NCT05181176 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Coffee
Description: 3 weight-loss interventions comprised of a similar dietary recommendation with either coffee (coffee group), tea (tea group) or placebo (herbal tea).
Study NCT05181176 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Green tea
Description: 3 weight-loss interventions comprised of a similar dietary recommendation with either coffee (coffee group), tea (tea group) or placebo (herbal tea).
Study NCT05181176 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Herbal tea (placebo)
Description: 3 weight-loss interventions comprised of a similar dietary recommendation with either coffee (coffee group), tea (tea group) or placebo (herbal tea).
Study NCT04716816 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stripping massage
Description: Stripping massage for rhomboid myofascial trigger points
Study NCT06452862 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic Resonance Imaging
Description: Both Diabetics and Healthy Volunteers will undergo MRI protocols including Blood Oxygen Level Dependence (BOLD), Intravoxel Incoherent Motion (IVIM), Arterial Spin Labeling (ASL), T1\&T2-mapping imaging and Magnetic Resonance Elastography (MRE). For Diabetics, blood tests for creatinine and cystatin C, along with blood pressure measurements, will be taken within a three-day window surrounding the MRE test. Additionally, Diabetics will undergo a renal biopsy to assess the extent of kidney damage.
Study NCT04911075 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 85% TCA Solution
Description: * TCA is an acetic acid analogue solution (CCl3COOH) which is formed from the reaction of acetic acid (CH3COOH) with chlorine (3Cl2).~* High concentrations (85 percent) of this solution can penetrate deeply into the epidermis-dermis layer and cause cells necrosis.~* This solution (1-2 milliliter) will be applied to participants cervical tissue (ectocervix and endocervix) using cotton swab for 1-3 minutes.
Study NCT05292339 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone injection to the shoulder, elbow, wrist, or hand
Description: Triamcinolone is a corticosteroid that decreases the inflammatory process by inhibiting the release of arachidonic acid from phospholipids.
Study NCT05292339 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketorolac injection to the shoulder, elbow, wrist, or hand
Description: Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that reduces inflammation by inhibiting Cyclo-oxygenase (COX)-2 dependent prostaglandin release via the cyclooxygenase pathway.
Study NCT06663566 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnose the patient&#39;s right heart function as well as right heart fibrosis
Description: Diagnose the patient\&#39;s right heart function as well as right heart fibrosis
Study NCT05990946 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ePRO based Remote Symptom Management provide by a mobile phone app
Description: Alerts are triggered if any of 5 core symptoms scored ≥4, prompting remote clinician feedback and guidance on symptom management. This is facilitated through the Shuyu mobile application, which serves as the platform for monitoring symptoms and communication.
Study NCT04552158 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Description: The Mediterranean diet (MedDiet) is a nutritional model inspired by the traditional dietary pattern of some of the countries of the Mediterranean basin. Mediterranean dietary pattern (MDP) gather the following characteristics: abundant consumption of olive oil and high consumption of fruits, vegetables, cereals (preferably as whole grain), legumes, nuts and seeds. The MDP also includes moderate consumption of fish and shellfish, white meat, eggs, and fermented dairy products (cheese and yogurt), as well as relatively small amounts of red meat, processed meats, and foods rich in sugars. Frequent but moderate intake of wine, especially red wine with meals is also recommended
Study NCT06537479 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Buteyko breathing technique
Description: Participants will be advised to sit in a comfortable and relaxed position and take a shallow breath through nose, partially filling the lungs. Hold breath for 2-3 seconds and exhale slowly through the nose and emptying the lungs.
Study NCT06537479 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Buteyko breathing technique
Description: Participants will be advised to sit in a comfortable and relaxed position and take a shallow breath through nose, partially filling the lungs. Hold breath for 2-3 seconds and exhale slowly through the nose and emptying the lungs.
Study NCT06537479 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chest Wall Mobilization
Description: It started with positioning, sitting or standing with good posture, and relaxing shoulders and arms. Hands were placed on the chest with fingers wide and thumbs on side of ribcage. Inhale deep breaths with expansion of chest and hands move outward. Exhale slowly allowed the chest to drop and the hands to move inward.
Study NCT00811031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Taxotere
Description: 75 mg/m\^2 Day 1 of every 21-day cycle by vein for 4 cycles prior to surgery.
Study NCT00811031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: 5 mg twice a day by mouth.
Study NCT06170632 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Biliary drainage
Description: Biliary drainage with FC-SEMS Niti-S FLARE TYPE
Study NCT06017856 — intervention group
Intervention type: OTHER
Intervention: Life style intervention program
Description: Life style intervention program for the obese/overweight subjects conducted regardless of this study at the child sport and health center at Meir medical center
Study NCT06023511 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation
Description: While study subjects are connected to standard ICU monitors, electrical muscle stimulation will be applied at the level of the quadriceps muscle to induce palpable or visible muscle contraction. (No control group or sham procedure in this study).
Study NCT05869227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine/Placebo combined with toripalimab
Description: Combined
Study NCT05869227 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Capecitabine/Placebo combined with toripalimab
Description: Combined
Study NCT06230367 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sexual health advocacy for guys
Description: 5 month HIV prevention program delivered via text messaging
Study NCT06230367 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Healthy lifestyle control
Description: 5 month control group program delivered via text messaging
Study NCT05927012 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KER-047
Description: Oral tablet, daily (or every other day) administration
Study NCT06461806 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein supplement - Plant protein
Description: Pea/lupine protein powder mix
Study NCT06461806 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein supplement - Animal protein
Description: Whey protein powder
Study NCT05348083 — intervention group
Intervention type: PROCEDURE
Intervention: ESPB
Description: Echo-guided bilateral ESPB performed at T9 level at the end of surgery with a mixture of ropivacaine 0.375% and epinephrine 5 mcg/mL 20 mL each side.
Study NCT05378269 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Description: Tamoxifen vaginal insert
Study NCT04843046 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules will be filled with corn starch and riboflavin.
Study NCT05378269 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo vaginal insert
Study NCT06380101 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NEAAR Medical Food
Description: Standardized non-essential amino acid restricted medical food.
Study NCT04698252 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Radiation therapy for oligometastatic sites
Study NCT04698252 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: Surgery for oligometastatic sites
Study NCT04698252 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Description: Radiofrequency ablation for oligometastatic sites
Study NCT05586399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Maximal strength training in COPD
Description: Participate in a rehabilitation program for 4 weeks, with exercise 5 times a week. Supervised maximal strength training in a leg press machine for a total of 20 exercise sessions. Patients will participate in rehabilitation in one of two rehabilitations centers in Trondheim, Norway.
Study NCT05190458 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: High Velocity Nasal Insufflation
Description: High velocity nasal insufflation (HVNI), a form of HFNC that utilizes a small bore nasal cannula to generate higher velocities of gas delivery than HFNC which uses large bore cannula, has the ability to accomplish complete purge of extra thoracic dead space at flow rates of 35 litres/min and may be able to provide ventilatory support in patients with respiratory failure in addition to oxygenation support in patients with overlap syndrome.
Study NCT05190458 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Non-invasive mechanical ventilation
Description: Noninvasive ventilation (NIV) refers to the administration of ventilatory support without using an invasive artificial airway (endotracheal tube or tracheostomy tube).
Study NCT05241223 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Behavior change intervention
Description: This is an online intervention based on the transtheoretical model, along with self-determination theory strategies. This intervention will take place weekly summing up 12 online individual and/or group sessions of approximately 20 minutes. The sessions will be made through a platform and/or application that makes video calls privately. Each session will address a topic. In addition, in all sessions, the patients gain during the previous week will be recognized, as well as new goals will be set for the next week. The goals will always be individualized, realistic and achievable, based on the identification of each person's capacity and motivation. A Fitbit Zip will be used to propose objective goals aimed at increasing physical activity and reduce sedentary behavior. Additionally, a complex practice environment will be created around this device, such as the visualization of the number of steps evolution and competitions/games with other participants, among others.
Study NCT05241223 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Educational program
Description: The educational program will be delivered similarly to both groups through videos and booklets, which will be sent in all weekdays during de first week after the initial assessment. Later, one educational material will be sent every two weeks until de 11th week. In the first day, patients will receive a quick welcome video call, in which information will be provided on how this program will work. In the subsequent days, the material will be sent daily and the participants will be able to ask questions, if they want to. The program will cover information regarding the respiratory system, pathophysiology of asthma, asthma treatment, prevention strategies and medication instructions. It will also be briefly addressed the subjects: understanding physical activity and sedentarism, as well as the importance and benefits of being physically active and less sedentary.
Study NCT04962568 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: DTEE
Description: endexpiratory diaphragm thickness in mm
Study NCT06264271 — intervention group
Intervention type: BEHAVIORAL
Intervention: structured nutrition intervention
Description: Structured nutrition education on carbohydrate counting and flexible insulin dosing by qualified nutritionist.
Study NCT04962568 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: DTEI
Description: endinspiratory diaphragm thickness in mm
Study NCT04962568 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: DEx
Description: diaphragm excursion during rest and diaphragmatic excursion during maximal inspiration in mm
Study NCT03372148 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: pHRMi
Description: Pharyngeal High Resolution Manometry and Impedance swallowing function evaluation
Study NCT05253482 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: wet cupping therapy
Description: Vacuum cups will used on different acupuncture points to perform WCT: The one on the posterior median line, in the depression below the processus spinosus of the 7th cervical vertebra was DU 14 (Dazhui) point; the ones on the back, 3.0 cm lateral to the lower border of the spinous process of the 3rd thoracic vertebra interscapulum region were UB 42 (Pohu) bilateral points; and the ones on the back, 3.0 cm lateral to the lower border of the spinous process of the 7th thoracic vertebra were UB 46 (Geguan) bilateral points and additionally the patient's trigger points which we detect during the examination. There will be 5-7 points in total. The technique used will be triple S (Sucking, Scarification, Sucking) in all sessions.
Study NCT06329154 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy
Description: The experimental group received extracorporeal shock wave therapy combined with conventional rehabilitation therapy. The control group was only given conventional rehabilitation therapy. According to the patient's tolerance and the specific condition, extracorporeal shock wave therapy was performed twice a week, 2000-3000 times each time, energy parameters of 2.5-3.5Bar, 8-15Hz, treatment interval > 1 day, consecutive 4 weeks. Conventional rehabilitation therapy included medium frequency electricity, ultrasound, ultrashort wave, laser and wax therapy. Routine rehabilitation was given once a day, 5 times a week for 4 weeks.
Study NCT06329154 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional rehabilitation therapy
Description: Conventional rehabilitation therapy included medium frequency electricity, ultrasound, ultrashort wave, laser, and wax therapy (same as the control group). Routine rehabilitation was given once a day, 5 times a week for 4 weeks.
Study NCT06118294 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: probiotics
Description: >30 billion CFU/capsule
Study NCT06118294 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05943444 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Parks technique
Description: compare different operational styles of low rectal cancer
Study NCT06016127 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: iovera system
Description: The iovera° system consists of a reusable, portable Handpiece, along with single patient use sterile Smart Tips (i.e., cryoprobes) and disposable nitrous oxide (N2O) cartridges. The iovera° system produces the desired effect through initiation of a cooling cycle. Each cooling cycle is initiated by fully inserting the Smart Tip into the selected procedure site and activating the cryogen flow. The Smart Tip needles are made of stainless steel and have a closed tip, fully enclosing the cryogen. The 190 Smart Tip will be used in this study.
Study NCT06016127 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency ablation
Description: The RFA system consists of a Cosman, G4 Generator. The needles used are 20-gauge, 10cm long with a 10mm active tip manufactured by Cosman. A grounding pad, also manufactured by Cosman, is placed on the upper thigh for each procedure and connected to the G4 Generator.
Study NCT05492721 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 2-Octylcyanoacrylate
Description: Incisions on left will have one glue and on right will have the other glue
Study NCT05943444 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bacon technique
Description: Bacon technique
Study NCT05120193 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mapping and Ablation
Description: Minimally invasive catheter mapping and ablation procedure
Study NCT05120193 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Mapping and Ablation
Description: Minimally invasive catheter mapping and ablation procedure
Study NCT06444620 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DTG/3TC
Description: This is a fixed-dose combined DTG/3TC pill each containing 50mg of dolutegravir and 300mg of lamivudine
Study NCT05492721 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: N-butyl-2-cyanoacrylate
Description: Incisions on left will have one glue and on right will have the other glue
Study NCT05820256 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Milk Protein Isolate (MPI)
Description: Study participants will consume two smoothies per day containing a milk protein isolate (MPI) for 31 days.
Study NCT05820256 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Soy Protein Isolate (SPI)
Description: Study participants will consume two smoothies per day containing a soy protein isolate (SPI) for 31 days.
Study NCT05656404 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TorEx Lung Perfusion System
Description: When donor lungs with clinical indication for EVLP are allocated to consented recipients, the lungs will be assessed using the second generation TorEx Lung Perfusion System rather than the first generation Toronto EVLP technique (standard of care).
Study NCT06090487 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: myocardial function after surgery
Description: This group includes (15) patients who will have 200 mg twice daily oral (5) sacubitril-valsartan 1 month before the operation. transthoracic echo will be done before and after surgery, also total dose if inoptropic drugs will be noted
Study NCT04922801 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Nuclear Medicine whole-body
Description: Gamma-Camera Whole-body scan at 24-48 hour post-Molecular Radiotherapy (MRT).
Study NCT04922801 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: SPECT/CT imaging.
Description: SPECT/CT scan at 24-48 hr post MRT
Study NCT04922801 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PET/CT imaging.
Description: 3-6 months Pre and post-therapy PET/CT imaging